Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02565004 · ClinicalTrials.gov registry record
Clinical and Laboratory Analysis of Familial Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 19
- Enrollment target
NCT02565004: Completed study, sponsored by National Cancer Institute (NCI).
NCT02565004 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02565004 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Background: DNA makes up the instruction book for people s cells. Cancer is a disease caused by DNA changes that build up and affect cell function. Researchers want to learn more about what may cause cancer by testing the DNA of people with the disease and their family members. Objective: To find DNA changes that may be inherited and may cause or influence whether a person gets cancer. To study families with clusters of cancer to find out if there is a DNA mutation specific to certain cancers. Eligibility: People 18 years of age and older who: Participated in the familial genetic part of NIH study 09-C-0079, a previous study or had family members enrolled in this study Design: Participants may have been screened in the previous study. They will give permission for researchers to use their data and their tissue or blood samples collected in the study. Participants may give blood samples. At each stage of testing, participants will meet with a genetics health care provider. The provider will explain the tests and answer questions. If researchers find a DNA change that might increase the risk for cancer or other health issues, they will confirm this result in a testing lab. This will require a blood sample. Participants personal DNA data and health information will be put in a database for research purposes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-09-28 |
| Est. Completion | 2020-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02565004
The ClinicalTrials.gov registry entry for NCT02565004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02565004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02565004 about?
NCT02565004 is a clinical study titled "Clinical and Laboratory Analysis of Familial Cancer". Background: DNA makes up the instruction book for people s cells. Cancer is a disease caused by DNA changes that build up and affect cell function. Researchers want to learn more about what may cause cancer by testing the DNA of people with the disease and their family members. Objective: To find...
What is the current status of trial NCT02565004?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2015-09-28. Estimated completion is 2020-07-31.
Who is sponsoring clinical trial NCT02565004?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.